StockData
Jushi Holdings Inc. logo

Jushi Holdings Inc. (JUSH) stock

JUSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 1/30
$0.49−0.03 (-5.50%)

Close on Oct 19, 2026Market cap $98.11MP/E –Yield –

Jushi Holdings Inc. grew revenue 6.2% to $276.54M over the twelve months to Sep 30, 2026. Operating income rose 195.5% to $6.59M, moving the operating margin from 0.9% to 2.4%. Free cash flow was $6.08M, up 66.5% from a year earlier. At the latest close the market valued the company at $98.11M.

Revenue
$276.54M
+6.2% vs. a year earlier
Operating income
$6.59M
+195.5% vs. a year earlier
Free cash flow
$6.08M
+66.5% vs. a year earlier
EPS, diluted
-$0.35
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$98.11M
P/E ratio
–
Price to sales
0.35
Price to book
–
Dividend yield
–
Free cash flow yield
6.20%

Fundamentals

Revenue
$276.54M
Net income
-$68.59M
EPS, diluted
-$0.35
Free cash flow
$6.08M
Book value per share
-$0.78
Diluted shares
198M

Trading

Next earnings
Mar 30, 2027 (estimated, during market hours)
Previous close
$0.52
Open
$0.48
Day's range
$0.47 – $0.51
Volume
143,092
Average volume (20 days)
244,274

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodJUSHS&P 500DifferenceJUSH per yearS&P 500 per year
1 month-22.5%+0.6%−23.1 pts
3 months+14.1%+3.4%+10.7 pts
Year to date-21.4%+13.3%−34.7 pts
1 year-34.0%+16.6%−50.6 pts
3 years-34.5%+86.4%−120.9 pts-13.2%+23.1%
5 years-87.8%+81.9%−169.6 pts-34.3%+12.7%

Seven years at a glance

Fiscal years 2019 to 2025 and trailing twelve months, USD

Revenue

$276.54M+6.2% YoY

Gross profit

$122.36M+10.5% YoY

Operating income

$6.59M+195.5% YoY

Net income

–

EPS, diluted

–

Free cash flow

$6.08M+66.5% YoY
Reported periodTrailing twelve months

Press releases

Releases Jushi filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Jushi

Medicinal Chemicals & Botanical Products

The company is a vertically integrated cannabis operator in the United States that cultivates, processes, distributes, and sells cannabis products. Its operations encompass retail dispensaries and wholesale distribution to licensed third parties. The product catalog includes dried flower, pre-rolls, vaporizers, concentrates, infused edibles such as gummies and chocolates, tinctures, capsules, and topicals. It also supplies bulk raw materials to other manufacturers. The company serves both registered medical patients and adult-use recreational consumers.

Company profile, executives and history

Jushi stock: common questions

What is Jushi's stock price?

JUSH closed at $0.49 on Oct 19, 2026, down 5.50% on the day.

What is Jushi's market cap?

Jushi was worth $98.11M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is JUSH's P/E ratio?

Jushi lost money over fiscal 2025 (diluted EPS -$0.35), so it has no meaningful P/E ratio.

How much revenue does Jushi make?

Jushi reported revenue of $276.54M for the twelve months to Sep 30, 2026, up 6.2% from a year earlier.

Does Jushi pay a dividend?

No. Jushi has not paid a cash dividend over the last twelve months.

When does Jushi report earnings next?

Jushi is expected to report Q4 FY2026 results on Mar 30, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has JUSH stock performed over the past year?

Including dividends, JUSH returned -34.0% over the past year, against +16.6% for the S&P 500.

Who are Jushi's competitors?

Companies most similar to Jushi by business, industry and size include AAWH, MRMD, CRLBF, CGC, TRLV.

See a number that looks wrong?